Colgate-Palmolive (CL) Misses Q1 EPS by 1c

Colgate-Palmolive (NYSE: CL) reported Q1 EPS of $0.74, $0.01 worse than the analyst estimate of $0.75. Revenue for the quarter came in at $4.4 billion versus the consensus estimate of $4.4 billion.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c